These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 35601418)

  • 1. Stevens-Johnson Syndrome Following Non-steroidal Anti-inflammatory Drugs: A Real-World Analysis of Post-marketing Surveillance Data.
    Shao QH; Yin XD; Zeng N; Zhou ZX; Mao XY; Zhu Y; Zhao B; Li ZL
    Front Pediatr; 2022; 10():896867. PubMed ID: 35601418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kidney Injury Following Ibuprofen and Acetaminophen: A Real-World Analysis of Post-Marketing Surveillance Data.
    Shao QH; Yin XD; Liu HX; Zhao B; Huang JQ; Li ZL
    Front Pharmacol; 2021; 12():750108. PubMed ID: 35002695
    [No Abstract]   [Full Text] [Related]  

  • 3. Stevens-Johnson Syndrome Following Vancomycin and Linezolid: A Real-World Analysis of Post-Marketing Surveillance Data.
    Ni M; Yin XD; Hu WJ; Zeng N; Zhao B; Li ZL
    Front Pharmacol; 2022; 13():872854. PubMed ID: 35571089
    [No Abstract]   [Full Text] [Related]  

  • 4. Stevens-Johnson syndrome and toxic epidermal necrolysis with antiepileptic drugs: An analysis of the US Food and Drug Administration Adverse Event Reporting System.
    Borrelli EP; Lee EY; Descoteaux AM; Kogut SJ; Caffrey AR
    Epilepsia; 2018 Dec; 59(12):2318-2324. PubMed ID: 30395352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal adverse effects following the use of different immune checkpoint inhibitor regimens: A real-world pharmacoepidemiology study of post-marketing surveillance data.
    Chen G; Qin Y; Fan QQ; Zhao B; Mei D; Li XM
    Cancer Med; 2020 Sep; 9(18):6576-6585. PubMed ID: 32720449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in vietnamese spontaneous adverse drug reaction database: A subgroup approach to disproportionality analysis.
    Nguyen KD; Tran TN; Nguyen MT; Nguyen HA; Nguyen HA; Vu DH; Nguyen VD; Bagheri H
    J Clin Pharm Ther; 2019 Feb; 44(1):69-77. PubMed ID: 30129156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Life-threatening dermatologic adverse events in oncology.
    Rosen AC; Balagula Y; Raisch DW; Garg V; Nardone B; Larsen N; Sorrell J; West DP; Anadkat MJ; Lacouture ME
    Anticancer Drugs; 2014 Feb; 25(2):225-34. PubMed ID: 24108082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocarditis following the use of different immune checkpoint inhibitor regimens: A real-world analysis of post-marketing surveillance data.
    Fan Q; Hu Y; Yang C; Zhao B
    Int Immunopharmacol; 2019 Nov; 76():105866. PubMed ID: 31491729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Making Rash Decisions in Epilepsy: Evaluating Hypersensitivity Reactions to Anti-seizure Medications.
    Bermeo-Ovalle A
    Epilepsy Curr; 2019; 19(2):96-98. PubMed ID: 30955419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stevens-Johnson syndrome/toxic epidermal necrolysis in patients treated with immune checkpoint inhibitors: A safety analysis of clinical trials and FDA pharmacovigilance database.
    Zhu J; Chen G; He Z; Zheng Y; Gao S; Li J; Ling Y; Yu X; Qiu K; Wu J
    EClinicalMedicine; 2021 Jul; 37():100951. PubMed ID: 34386743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis using the Japanese Adverse Drug Event Report database.
    Abe J; Umetsu R; Mataki K; Kato Y; Ueda N; Nakayama Y; Hane Y; Matsui T; Hatahira H; Sasaoka S; Motooka Y; Hara H; Kato Z; Kinosada Y; Inagaki N; Nakamura M
    J Pharm Health Care Sci; 2016; 2():14. PubMed ID: 27330825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colitis following the use of immune checkpoint inhibitors: A real-world analysis of spontaneous reports submitted to the FDA adverse event reporting system.
    Hu Y; Gong J; Zhang L; Li X; Li X; Zhao B; Hai X
    Int Immunopharmacol; 2020 Jul; 84():106601. PubMed ID: 32422528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe adverse skin reactions to nonsteroidal antiinflammatory drugs: A review of the literature.
    Ward KE; Archambault R; Mersfelder TL
    Am J Health Syst Pharm; 2010 Feb; 67(3):206-13. PubMed ID: 20101062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-induced Stevens-Johnson syndrome: a disproportionality analysis from the pharmacovigilance database of the World Health Organization.
    Zheng Y; Zhou W; Guo X; Chi L; Chen C; Guo Z; Liang J; Wei L; Chen X; Ye X; He J
    Expert Opin Drug Saf; 2022 Aug; 21(8):1127-1133. PubMed ID: 35196201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Data Mining FAERS to Analyze Molecular Targets of Drugs Highly Associated with Stevens-Johnson Syndrome.
    Burkhart KK; Abernethy D; Jackson D
    J Med Toxicol; 2015 Jun; 11(2):265-73. PubMed ID: 25876064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors.
    La Grenade L; Lee L; Weaver J; Bonnel R; Karwoski C; Governale L; Brinker A
    Drug Saf; 2005; 28(10):917-24. PubMed ID: 16180941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of gastrointestinal complications associated to NSAIDs, low-dose aspirin and their combinations: Results of a pharmacovigilance reporting system.
    Rafaniello C; Ferrajolo C; Sullo MG; Sessa M; Sportiello L; Balzano A; Manguso F; Aiezza ML; Rossi F; Scarpignato C; Capuano A
    Pharmacol Res; 2016 Feb; 104():108-14. PubMed ID: 26739516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute kidney injury following the use of different proton pump inhibitor regimens: A real-world analysis of post-marketing surveillance data.
    Chen G; Ning LJ; Qin Y; Zhao B; Mei D; Li XM
    J Gastroenterol Hepatol; 2021 Jan; 36(1):156-162. PubMed ID: 32542684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemorrhage Risk Profiles among Different Antithrombotic Regimens: Evidence from a Real-World Analysis of Postmarketing Surveillance Data.
    Sun X; Ze B; Zhang LJ; BaiMa YZ; Zuo W; Zhao B; GeSang LB
    Cardiovasc Drugs Ther; 2022 Feb; 36(1):103-112. PubMed ID: 33226545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Stevens-Johnson syndrome and toxic epidermal necrolysis with antiepileptic drugs in pediatric patients: Subgroup analysis based on a Japanese spontaneous database.
    Inada A; Oyama S; Niinomi I; Wakabayashi T; Iwanaga K; Hosohata K
    J Clin Pharm Ther; 2019 Oct; 44(5):775-779. PubMed ID: 31231846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.